Multiplex Assay Kit for Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay)

PRG; PPG; PRG1; proteoglycan 1, secretory granule

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 83-94 89
EDTA plasma(n=5) 93-101 98
heparin plasma(n=5) 85-101 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-103% 83-101% 97-105% 94-103%
EDTA plasma(n=5) 78-101% 79-101% 91-102% 99-105%
heparin plasma(n=5) 79-91% 82-96% 81-90% 94-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:SRGN) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Irish Journal of Medical Science The role of increased synovial fluid A disintegrin and metalloproteinase with thrombospondin motifs4 and serglycin levels in osteoarthritis Pubmed: 30536194
MOLECULAR AND CELLULAR BIOCHEMISTRY SRGN, a new identified shear-stress-responsive gene in endothelial cells Pubmed: 32712749
Theranostics Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer 33456569
CELLULAR ONCOLOGY Cancer©\associated fibroblasts secrete hypoxia©\induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by ¡­ 33651283
Cell Death Dis Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone 34556636
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC869Hu01 Recombinant Serglycin (SRGN) Positive Control; Immunogen; SDS-PAGE; WB.
CPC869Hu21 OVA Conjugated Serglycin (SRGN) Immunogen; SDS-PAGE; WB.
PAC869Hu01 Polyclonal Antibody to Serglycin (SRGN) WB; IHC; ICC; IP.
MAC869Hu22 Monoclonal Antibody to Serglycin (SRGN) WB,IHC
MAC869Hu21 Monoclonal Antibody to Serglycin (SRGN) WB; IHC; ICC; IP.
SEC869Hu ELISA Kit for Serglycin (SRGN) Enzyme-linked immunosorbent assay for Antigen Detection.
CEC869Hu ELISA Kit for Serglycin (SRGN) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC869Hu Multiplex Assay Kit for Serglycin (SRGN) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.